Accueil/Actions/CNSP

CNSP

USD

CNS Pharmaceuticals Inc. Common Stock

$6.600-0.420 (-5.983%)

Prix en Temps Réel

Healthcare

Biotechnologie

États-Unis

Graphique des Prix

Loading Chart...

Métriques Clés

Métriques de Marché

Fondamentaux de l'Entreprise

Statistiques de Trading

Métriques de Marché

Ouverture

$7.020

Haut

$7.020

Bas

$6.500

Volume

0.01M

Fondamentaux de l'Entreprise

Capitalisation Boursière

3.8M

Industrie

Biotechnologie

Pays

United States

Statistiques de Trading

Volume Moyen

0.05M

Bourse

NCM

Devise

USD

Intervalle sur 52 Semaines

Bas $4.93Actuel $6.600Haut $114

Actualités Connexes

12 sept. 2025 · 14:08

Analyst Upgrades

Maxim Group Upgrades CNS Pharma to Buy, Announces $20 Price Target

Maxim Group analyst Jason McCarthy upgrades CNS Pharma from Hold to Buy and announces $20 price target.

Maxim Group Upgrades CNS Pharma to Buy, Announces $20 Price Target

3 sept. 2025 · 13:15

AccessWire

CNS Pharmaceuticals to Present at the H.C. Wainwright 27th Annual Global Investment Conference

HOUSTON, TX / ACCESS Newswire / September 3, 2025 / CNS Pharmaceuticals, Inc. , a biopharmaceutical company specializing in the development of novel treatments

CNS Pharmaceuticals to Present at the H.C. Wainwright 27th Annual Global Investment Conference

27 août 2025 · 12:00

GlobeNewswire

IBN Announces Latest Episode of The BioMedWire Podcast Featuring John Climaco, CEO of CNS Pharmaceuticals Inc.

AUSTIN, Texas, Aug. 27, 2025 (GLOBE NEWSWIRE) -- -- via IBN -- IBN, a multifaceted communications organization engaged in connecting public companies to the investment community, is pleased to announce the release of